No attachments available.
Protective Clothing Blood Penetration Resistance Tester
Contact and place of performance
Warren Dutter
Winchester, MA 01890
USA
MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS) is issuing this source sought announcement on behalf of the Center for Devices and Radiological Health (CDRH), in order to determine if there are existing small business sources capable of providing a Protective Clothing Blood Penetration Resistance Te...
View moreBackground:
The U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Winchester Engineering and Analytical Center Laboratory (WEAC), requires the purchase of one (1) Protective Clothing Blood Penetration Resistance Tester to support future regulatory testing.
The Protective Clothing Blood Penetration Resistance Tester will be used to perform a verification method to test for viral penetration of level 4 medical gowns at the request of CDRH. Level 4 medical gowns provide the highest level of protection against bloodborne pathogens; they are critical in protecting healthcare workers used during risk medical procedures. The gold standard in testing is performed manually and takes specific expertise and an excess of 100 hours to complete. This automated tester would cut hands on time by 75% while increasing consistency and repeatability to the test.
Minimum Technical Requirements:
Additional System Requirements:
Delivery/Place of Performance:
FOB Point Destination. All items shall include shipping, handling, installation, IQ/OQ, and inside delivery to the destination identified herein.
U. S. Food and Drug Administration
Winchester Engineering and Analytical Center
109 Holton Street
Winchester, MA 01890
Delivery shall be coordinated with the Contracting Officer Representative at least 48 hours in advance
Period of Performance:
Delivery shall occur within 120 days from date of award.
Responses to this Sources Sought shall unequivocally demonstrate that the respondent is regularly engaged in the sale of same or substantially similar product/service. Though the target audience is small business vendors or small businesses capable of supplying a U.S. service of a small business vendor or producer all interested parties may respond. At a minimum, responses shall include the following:
Interested Contractors must respond with capability statements which are due by email to the point of contact listed below on or before June 23, 2026, by 1:00 PM Central Time at the Food and Drug Administration, Field Operations Branch, FDA|OO|OFBA|OAGS|DAP, Attn: Warren Dutter, email [email protected]. Reference: FDA-SSN-134448.
Disclaimer and Important Notes:
This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work.
Responses with weblinks will not be opened or viewed.
Responses must demonstrate capability, not merely affirm the respondent's capability (i.e. the response must go beyond the statement that, "XYZ company can provide the instrument, technical support etc.").
Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre‐solicitation synopsis and solicitation may be published in sam.gov. However, responses to this notice will not be considered adequate responses to a solicitation.
Confidentiality and Proprietary Information:
No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non‐proprietary technical information in any resultant solicitation(s).
Additional Notes:
If the stated requirements appear restrictive, please submit comments detailing the concern. Though this is not a request for quote, informational pricing for the service would be helpful.
This is a sources sought announcement, a market survey for written information only. This is not a solicitation announcement for proposals and no contract will be awarded from this announcement. No reimbursement will be made for any costs associated with providing information in response to this announcement or any follow-up information requests. No telephone calls will be accepted requesting an RFQ package or solicitation. There is no RFQ package or solicitation. In order to protect the procurement integrity of any future procurement, if any, that may arise from this announcement, information regarding the technical point of contact will not be given.
The Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), is conducting market research to identify small business sources capable of providing one newly manufactured Protective Clothing Blood Penetration Resistance Tester. This automated system will support regulatory testing at the Winchester Engineering and Analytical Center Laboratory (WEAC) by verifying viral penetration resistance in Level 4 medical gowns. The equipment must provide four independent working positions, an integrated touchscreen interface, and real-time pressure monitoring to ensure compliance with ASTM F1670 and ASTM F1671/F1671M standards. The requirement is classified under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing and PSC 6640 for Laboratory Equipment and Supplies.
The intended procurement is a turn-key solution including all hardware, software, installation, and shipping to Winchester, Massachusetts. The contractor will be responsible for providing Installation Qualification (IQ) and Operational Qualification (OQ) services, on-site operator training, and a minimum one-year warranty with technical support. Delivery of the system is required within 120 days from the date of award. While the FDA is specifically seeking small business concerns to determine the feasibility of a set-aside, other than small business concerns are also encouraged to submit capability statements, particularly those offering domestic products.
Responses to this Sources Sought notice, identified by solicitation number FDA-SSN-134448, must be submitted via email to Warren Dutter by June 23, 2026. Submissions must include business identifiers such as the Unique Entity Identification (UEI) number, size status, and descriptive literature detailing how the proposed equipment meets the specified technical requirements. The government also requests information regarding place of manufacture, past performance for similar sales, and any applicable government-wide contract vehicles or GSA Schedules.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.